BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24388360)

  • 1. SERPINA5 inhibits tumor cell migration by modulating the fibronectin-integrin β1 signaling pathway in hepatocellular carcinoma.
    Jing Y; Jia D; Wong CM; Oi-Lin Ng I; Zhang Z; Liu L; Wang Q; Zhao F; Li J; Yao M; Wu X; He X
    Mol Oncol; 2014 Mar; 8(2):366-77. PubMed ID: 24388360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular membrane-proximal domain of HAb18G/CD147 binds to metal ion-dependent adhesion site (MIDAS) motif of integrin β1 to modulate malignant properties of hepatoma cells.
    Li Y; Wu J; Song F; Tang J; Wang SJ; Yu XL; Chen ZN; Jiang JL
    J Biol Chem; 2012 Feb; 287(7):4759-72. PubMed ID: 22130661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway.
    Song Y; Ye L; Tan Y; Tong H; Lv Z; Wan X; Li Y
    Cell Oncol (Dordr); 2022 Oct; 45(5):861-872. PubMed ID: 35951287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells.
    Huaman J; Naidoo M; Zang X; Ogunwobi OO
    Cells; 2019 Jun; 8(6):. PubMed ID: 31226820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF is highly expressed in hepatocellular carcinoma (HCC) and promotes motility of HCC cells via fibronectin.
    Liu Z; Chen D; Ning F; Du J; Wang H
    J Cell Biochem; 2018 May; 119(5):4170-4183. PubMed ID: 29315755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma.
    Devbhandari RP; Shi GM; Ke AW; Wu FZ; Huang XY; Wang XY; Shi YH; Ding ZB; Xu Y; Dai Z; Fan J; Zhou J
    PLoS One; 2011; 6(9):e24901. PubMed ID: 21961047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate early response protein 2 regulates hepatocellular carcinoma cell adhesion and motility via integrin β1-mediated signaling pathway.
    Xu Z; Zhu L; Wu W; Liao Y; Zhang W; Deng Z; Shen J; Yuan Q; Zheng L; Zhang Y; Shen W
    Oncol Rep; 2017 Jan; 37(1):259-272. PubMed ID: 27840969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HAb18G/CD147 promotes radioresistance in hepatocellular carcinoma cells: a potential role for integrin β1 signaling.
    Wu J; Li Y; Dang YZ; Gao HX; Jiang JL; Chen ZN
    Mol Cancer Ther; 2015 Feb; 14(2):553-63. PubMed ID: 25534361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.
    Wu S; Zheng Q; Xing X; Dong Y; Wang Y; You Y; Chen R; Hu C; Chen J; Gao D; Zhao Y; Wang Z; Xue T; Ren Z; Cui J
    J Exp Clin Cancer Res; 2018 May; 37(1):99. PubMed ID: 29728125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma.
    Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism.
    Tang JC; Liu JH; Liu XL; Liang X; Cai XJ
    World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
    Zha R; Guo W; Zhang Z; Qiu Z; Wang Q; Ding J; Huang S; Chen T; Gu J; Yao M; He X
    PLoS One; 2014; 9(2):e87665. PubMed ID: 24498348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
    Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
    PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma.
    Yu J; Xu QG; Wang ZG; Yang Y; Zhang L; Ma JZ; Sun SH; Yang F; Zhou WP
    J Hepatol; 2018 Jun; 68(6):1214-1227. PubMed ID: 29378234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix stiffness-mediated effects on stemness characteristics occurring in HCC cells.
    You Y; Zheng Q; Dong Y; Xie X; Wang Y; Wu S; Zhang L; Wang Y; Xue T; Wang Z; Chen R; Wang Y; Cui J; Ren Z
    Oncotarget; 2016 May; 7(22):32221-31. PubMed ID: 27050147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma.
    Li Y; Ren Z; Wang Y; Dang YZ; Meng BX; Wang GD; Zhang J; Wu J; Wen N
    Exp Cell Res; 2018 Sep; 370(2):373-382. PubMed ID: 29966664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
    Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X
    Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
    Fang T; Lv H; Lv G; Li T; Wang C; Han Q; Yu L; Su B; Guo L; Huang S; Cao D; Tang L; Tang S; Wu M; Yang W; Wang H
    Nat Commun; 2018 Jan; 9(1):191. PubMed ID: 29335551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis.
    Xu X; Liu Z; Zhou L; Xie H; Cheng J; Ling Q; Wang J; Guo H; Wei X; Zheng S
    J Exp Clin Cancer Res; 2015 Jan; 34(1):6. PubMed ID: 25609232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
    Bao L; Zhang M; Han S; Zhan Y; Guo W; Teng F; Liu F; Guo M; Zhang L; Ding G; Wang Q
    Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.